CONBRIZA

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

BAZEDOXIFENE AS ACETATE 20 MG

可用日期:

NEOPHARM LTD

ATC代码:

G03XC02

药物剂型:

COATED TABLETS

给药途径:

PER OS

厂商:

PFIZER IRELAND PHARMACEUTICALS

治疗组:

BAZEDOXIFENE

疗效迹象:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

授权日期:

2013-04-01